{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:16:20Z","timestamp":1783502180733,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003825","name":"Magyar Tudom\u00e1nyos Akad\u00e9mia","doi-asserted-by":"publisher","award":["Pr\u00e9mium Postdocoral Grant"],"award-info":[{"award-number":["Pr\u00e9mium Postdocoral Grant"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Magyar Tudom\u00e1nyos Akad\u00e9mia","doi-asserted-by":"publisher","award":["LP2021-2"],"award-info":[{"award-number":["LP2021-2"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["OTKA FK141322"],"award-info":[{"award-number":["OTKA FK141322"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hungarian National Scientific Fund","award":["OTKA K138970"],"award-info":[{"award-number":["OTKA K138970"]}]},{"name":"ELKH Centre for Economic and Regional Studies"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Many countries have secured larger quantities of COVID-19 vaccines than their population is willing to take. The abundance and the large variety of vaccines created not only an unprecedented intensity of vaccine related public discourse, but also a historical moment to understand vaccine hesitancy better. Yet, the heterogeneity of hesitancy by vaccine types has been neglected in the existing literature so far. We address this problem by analysing the acceptance and the assessment of five vaccine types. We use information collected with a nationally representative survey at the end of the third wave of the COVID-19 pandemic in Hungary. During the vaccination campaign, individuals could reject the assigned vaccine to wait for a more preferred alternative that enables us to quantify revealed preferences across vaccine types. We find that hesitancy is heterogenous by vaccine types and is driven by individuals\u2019 trusted source of information. Believers of conspiracy theories are more likely to evaluate the mRNA vaccines (Pfizer and Moderna) unacceptable. Those who follow the advice of politicians are more likely to evaluate vector-based (AstraZeneca and Sputnik) or whole-virus vaccines (Sinopharm) acceptable. We argue that the greater selection of available vaccine types and the free choice of the individual are desirable conditions to increase the vaccination rate in societies.<\/jats:p>","DOI":"10.1038\/s41598-022-15633-5","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T19:12:15Z","timestamp":1659467535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Understanding hesitancy with revealed preferences across COVID-19 vaccine types"],"prefix":"10.1038","volume":"12","author":[{"given":"Krist\u00f3f","family":"Kutasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia","family":"Koltai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Szab\u00f3-Morvai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergely","family":"R\u00f6st","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rton","family":"Karsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Bir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,2]]},"reference":[{"key":"15633_CR1","doi-asserted-by":"crossref","unstructured":"Cohen, J. Vaccine designers take first shots at COVID-19 (2020).","DOI":"10.1126\/science.368.6486.14"},{"key":"15633_CR2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1126\/science.abb8923","volume":"368","author":"BS Graham","year":"2020","unstructured":"Graham, B. S. Rapid COVID-19 vaccine development. Science 368, 945\u2013946 (2020).","journal-title":"Science"},{"key":"15633_CR3","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1126\/science.abc5312","volume":"368","author":"L Corey","year":"2020","unstructured":"Corey, L., Mascola, J. R., Fauci, A. S. & Collins, F. S. A strategic approach to COVID-19 vaccine R&D. Science 368, 948\u2013950 (2020).","journal-title":"Science"},{"key":"15633_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","volume":"27","author":"JV Lazarus","year":"2021","unstructured":"Lazarus, J. V. et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. 27, 225\u2013228 (2021).","journal-title":"Nat. Med."},{"key":"15633_CR5","doi-asserted-by":"crossref","unstructured":"Machingaidze, S. & Wiysonge, C.\u00a0S. Understanding COVID-19 vaccine hesitancy. Nat. Med., 1\u20132 (2021).","DOI":"10.1038\/s41591-021-01459-7"},{"key":"15633_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/vaccines9020160","volume":"9","author":"M Sallam","year":"2021","unstructured":"Sallam, M. COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines 9, 160 (2021).","journal-title":"Vaccines"},{"key":"15633_CR7","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/s41591-021-01454-y","volume":"27","author":"JS Sol\u00eds\u00a0Arce","year":"2021","unstructured":"Sol\u00eds\u00a0Arce, J. S. et al. COVID-19 vaccine acceptance and hesitancy in low-and middle-income countries. Nat. Med. 27, 1385\u20131394 (2021).","journal-title":"Nat. Med."},{"key":"15633_CR8","doi-asserted-by":"publisher","first-page":"e0257096","DOI":"10.1371\/journal.pone.0257096","volume":"16","author":"S Mahmud","year":"2021","unstructured":"Mahmud, S., Mohsin, M., Khan, I. A., Mian, A. U. & Zaman, M. A. Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh. PLoS One 16, e0257096 (2021).","journal-title":"PLoS One"},{"key":"15633_CR9","doi-asserted-by":"crossref","unstructured":"Zintel, S. et\u00a0al. Gender differences in the intention to get vaccinated against COVID-19: A systematic review and meta-analysis. J. Public Health, 1\u201325 (2022).","DOI":"10.1007\/s10389-021-01677-w"},{"key":"15633_CR10","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(21)00306-8","volume":"397","author":"OJ Wouters","year":"2021","unstructured":"Wouters, O. J. et al. Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment. Lancet 397, 1023\u20131034 (2021).","journal-title":"Lancet"},{"key":"15633_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41591-021-01334-5","volume":"27","author":"G Giordano","year":"2021","unstructured":"Giordano, G. et al. Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy. Nat. Med. 27, 993\u2013998 (2021).","journal-title":"Nat. Med."},{"key":"15633_CR12","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1126\/science.abe6959","volume":"371","author":"KM Bubar","year":"2021","unstructured":"Bubar, K. M. et al. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science 371, 916\u2013921 (2021).","journal-title":"Science"},{"key":"15633_CR13","doi-asserted-by":"publisher","first-page":"eabf1374","DOI":"10.1126\/sciadv.abf1374","volume":"7","author":"L Matrajt","year":"2021","unstructured":"Matrajt, L., Eaton, J., Leung, T. & Brown, E. R. Vaccine optimization for COVID-19: Who to vaccinate first?. Sci. Adv. 7, eabf1374 (2021).","journal-title":"Sci. Adv."},{"key":"15633_CR14","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0140-6736(21)01808-0","volume":"398","author":"V Priesemann","year":"2021","unstructured":"Priesemann, V. et al. Towards a European strategy to address the COVID-19 pandemic. Lancet 398, 838\u2013839 (2021).","journal-title":"Lancet"},{"key":"15633_CR15","doi-asserted-by":"crossref","unstructured":"Mahmud, S., Mohsin, M., Hossain, S., Islam, M.\u00a0M. & Muyeed, A. The acceptance of COVID-19 vaccine: A global rapid systematic review and meta-analysis. Available at SSRN 3855987 (2021).","DOI":"10.2139\/ssrn.3855987"},{"key":"15633_CR16","first-page":"E47","volume":"57","author":"R Rosselli","year":"2016","unstructured":"Rosselli, R., Martini, M. & Bragazzi, N. L. The old and the new: Vaccine hesitancy in the era of the web 2.0. challenges and opportunities. J. Prev. Med. Hyg. 57, E47 (2016).","journal-title":"J. Prev. Med. Hyg."},{"key":"15633_CR17","doi-asserted-by":"crossref","unstructured":"Troiano, G. & Nardi, A. Vaccine hesitancy in the era of COVID-19. Public Health (2021).","DOI":"10.1016\/j.puhe.2021.02.025"},{"key":"15633_CR18","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1016\/S2468-2667(21)00096-7","volume":"6","author":"D Freeman","year":"2021","unstructured":"Freeman, D. et al. Effects of different types of written vaccination information on covid-19 vaccine hesitancy in the UK (oceans-III): A single-blind, parallel-group, randomised controlled trial. Lancet Public Health 6, e416\u2013e427 (2021).","journal-title":"Lancet Public Health"},{"key":"15633_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41562-021-01056-1","volume":"5","author":"S Loomba","year":"2021","unstructured":"Loomba, S., de Figueiredo, A., Piatek, S. J., de Graaf, K. & Larson, H. J. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat. Hum. Behav. 5, 337\u2013348 (2021).","journal-title":"Nat. Hum. Behav."},{"key":"15633_CR20","first-page":"100012","volume":"1","author":"E Paul","year":"2021","unstructured":"Paul, E., Steptoe, A. & Fancourt, D. Attitudes towards vaccines and intention to vaccinate against covid-19: Implications for public health communications. Lancet Reg. Health 1, 100012 (2021).","journal-title":"Lancet Reg. Health"},{"key":"15633_CR21","doi-asserted-by":"crossref","unstructured":"Sonawane, K., Troisi, C.\u00a0L. & Deshmukh, A.\u00a0A. COVID-19 vaccination in the UK: Addressing vaccine hesitancy. Lancet Reg. Health-Europe 1 (2021).","DOI":"10.1016\/j.lanepe.2020.100016"},{"key":"15633_CR22","doi-asserted-by":"publisher","first-page":"e048172","DOI":"10.1136\/bmjopen-2020-048172","volume":"11","author":"MF Lindholt","year":"2021","unstructured":"Lindholt, M. F., J\u00f8rgensen, F., Bor, A. & Petersen, M. B. Public acceptance of covid-19 vaccines: Cross-national evidence on levels and individual-level predictors using observational data. BMJ Open 11, e048172 (2021).","journal-title":"BMJ Open"},{"key":"15633_CR23","unstructured":"Schernhammer, E. et\u00a0al. Correlates of COVID-19 vaccine hesitancy in Austria: Trust and the government. J. Public Health (Oxford, England)."},{"key":"15633_CR24","doi-asserted-by":"crossref","unstructured":"Salali, G.\u00a0D. & Uysal, M.\u00a0S. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol. Med., 1\u20133 (2020).","DOI":"10.1017\/S0033291720004067"},{"key":"15633_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-20226-9","volume":"12","author":"J Murphy","year":"2021","unstructured":"Murphy, J. et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nat. Commun. 12, 1\u201315 (2021).","journal-title":"Nat. Commun."},{"key":"15633_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-021-10643-w","volume":"21","author":"A Soveri","year":"2021","unstructured":"Soveri, A., Karlsson, L. C., Antfolk, J., Lindfelt, M. & Lewandowsky, S. Unwillingness to engage in behaviors that protect against covid-19: The role of conspiracy beliefs, trust, and endorsement of complementary and alternative medicine. BMC Public Health 21, 1\u201312 (2021).","journal-title":"BMC Public Health"},{"key":"15633_CR27","doi-asserted-by":"crossref","unstructured":"B\u00edr\u00f3-Nagy, A. & Sz\u00e1szi, \u00c1.\u00a0J. The roots of COVID-19 vaccine hesitancy: Evidence from Hungary. J. Behav. Med., 1\u201316 (2022).","DOI":"10.1007\/s10865-022-00314-5"},{"key":"15633_CR28","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1126\/science.abe5938","volume":"370","author":"M Lipsitch","year":"2020","unstructured":"Lipsitch, M. & Dean, N. E. Understanding COVID-19 vaccine efficacy. Science 370, 763\u2013765 (2020).","journal-title":"Science"},{"key":"15633_CR29","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/d41586-021-00940-0","volume":"592","author":"H Ledford","year":"2021","unstructured":"Ledford, H. How could a COVID vaccine cause blood clots? Scientists race to investigate. Nature 592, 334\u2013335 (2021).","journal-title":"Nature"},{"key":"15633_CR30","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/S2468-2667(21)00012-8","volume":"6","author":"M Schwarzinger","year":"2021","unstructured":"Schwarzinger, M., Watson, V., Arwidson, P., Alla, F. & Luchini, S. Covid-19 vaccine hesitancy in a representative working-age population in France: A survey experiment based on vaccine characteristics. Lancet Public Health 6, e210\u2013e221 (2021).","journal-title":"Lancet Public Health"},{"key":"15633_CR31","doi-asserted-by":"crossref","unstructured":"Dror, A.\u00a0A. et\u00a0al. Vaccine hesitancy due to vaccine country of origin, vaccine technology, and certification. Eur. J. Epidemiol., 1\u20136 (2021).","DOI":"10.1007\/s10654-021-00758-0"},{"key":"15633_CR32","doi-asserted-by":"crossref","unstructured":"Goodwin, R. et\u00a0al. Psychological factors underpinning vaccine willingness in Israel, Japan and Hungary. medRxiv (2021).","DOI":"10.1101\/2021.05.24.21257465"},{"key":"15633_CR33","unstructured":"Ligeti, A.\u00a0S., Karsai, M., Koltai, J. & Gergely, R. A covid-19 elleni v\u00e9d\u0151olt\u00e1ssal kapcsolatos attit\u0171d\u00f6k a magyar t\u00e1rsadalomban. In Horn, D. & Bartal, A.\u00a0M. (eds.) Feh\u00e9r k\u00f6nyv a covid-19-j\u00e1rv\u00e1ny t\u00e1rsadalmi-gazdas\u00e1gi hat\u00e1sair\u00f3l, chap. 1.3, 33\u201342 (E\u00f6tv\u00f6s Lor\u00e1nd Kutat\u00e1si H\u00e1l\u00f3zat K\u00f6zgazdas\u00e1g- \u00e9s Region\u00e1lis Tudom\u00e1nyi Kutat\u00f3k\u00f6zpont, K\u00f6zgazdas\u00e1gtudom\u00e1nyi Int\u00e9zet, 2022)."},{"key":"15633_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-004206","volume":"5","author":"SL Wilson","year":"2020","unstructured":"Wilson, S. L. & Wiysonge, C. Social media and vaccine hesitancy. BMJ Global Health 5, e004206 (2020).","journal-title":"BMJ Global Health"},{"key":"15633_CR35","doi-asserted-by":"publisher","unstructured":"Kaplan, A.\u00a0K., Sahin, M.\u00a0K., Parildar, H. & Adadan\u00a0Guvenc, I. The willingness to accept the COVID-19 vaccine and affecting factors among healthcare professionals: A cross-sectional study in Turkey. Int. J. Clin. Pract., e14226. https:\/\/doi.org\/10.1111\/ijcp.14226 (2021).","DOI":"10.1111\/ijcp.14226"},{"key":"15633_CR36","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/bdm.1967","volume":"30","author":"J Luo","year":"2017","unstructured":"Luo, J. & Yu, R. The spreading of alternatives: Is it the perceived choice or actual choice that changes our preference?. J. Behav. Decis. Making 30, 484\u2013491 (2017).","journal-title":"J. Behav. Decis. Making"},{"key":"15633_CR37","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jval.2021.12.011","volume":"25","author":"R Dal-R\u00e9","year":"2022","unstructured":"Dal-R\u00e9, R., Farr\u00e9, M. & Lucena, M. I. Heterologous COVID-19 vaccination in Spain: A case study of individual autonomy in the real world. Value Health 25, 770\u2013772 (2022).","journal-title":"Value Health"},{"key":"15633_CR38","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ejim.2021.01.030","volume":"87","author":"R Dal-R\u00e9","year":"2021","unstructured":"Dal-R\u00e9, R., Stephens, R. & Sreeharan, N. Let me choose my COVID-19 vaccine. Eur. J. Intern. Med. 87, 104\u2013105 (2021).","journal-title":"Eur. J. Intern. Med."},{"key":"15633_CR39","doi-asserted-by":"crossref","unstructured":"Hughes, M.\u00a0T. et\u00a0al. Opinion: The importance of offering vaccine choice in the fight against covid-19. Proc. Natl. Acad. Sci. 118 (2021).","DOI":"10.1073\/pnas.2117185118"},{"key":"15633_CR40","doi-asserted-by":"crossref","unstructured":"Sprengholz, P., Eitze, S., Korn, L., Siegers, R. & Betsch, C. The power of choice: Experimental evidence that freedom to choose a vaccine against COVID-19 improves willingness to be vaccinated. Eur. J. Intern. Med. (2021).","DOI":"10.1016\/j.ejim.2021.03.015"},{"key":"15633_CR41","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/vaccines9080927","volume":"9","author":"L Salerno","year":"2021","unstructured":"Salerno, L., Crax\u00ec, L., Amodio, E. & Lo Coco, G. Factors affecting hesitancy to mRNA and viral vector COVID-19 vaccines among college students in Italy. Vaccines 9, 927 (2021).","journal-title":"Vaccines"},{"key":"15633_CR42","doi-asserted-by":"crossref","unstructured":"Steinert, J. et\u00a0al. COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants and heterogeneity. Sci. Adv. (2022).","DOI":"10.21203\/rs.3.rs-840045\/v1"},{"key":"15633_CR43","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3390\/vaccines9070718","volume":"9","author":"SF Abdelwahab","year":"2021","unstructured":"Abdelwahab, S. F., Issa, U. H. & Ashour, H. M. A novel vaccine selection decision-making model (VSDMM) for COVID-19. Vaccines 9, 718 (2021).","journal-title":"Vaccines"},{"key":"15633_CR44","doi-asserted-by":"crossref","unstructured":"Mohsin, M. et\u00a0al. Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh. medRxiv (2022).","DOI":"10.1101\/2022.01.31.22270172"},{"key":"15633_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ejsp.2420150303","volume":"15","author":"AJ Nederhof","year":"1985","unstructured":"Nederhof, A. J. Methods of coping with social desirability bias: A review. Eur. J. Soc. Psychol. 15, 263\u2013280 (1985).","journal-title":"Eur. J. Soc. Psychol."},{"key":"15633_CR46","doi-asserted-by":"crossref","unstructured":"Koltai, J., V\u00e1s\u00e1rhelyi, O., R\u00f6st, G. & Karsai, M. Monitoring behavioural responses during pandemic via reconstructed contact matrices from online and representative surveys. arXiv preprint arXiv:2102.09021 (2021).","DOI":"10.1038\/s41598-022-07488-7"},{"key":"15633_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-07488-7","volume":"12","author":"J Koltai","year":"2022","unstructured":"Koltai, J., V\u00e1s\u00e1rhelyi, O., R\u00f6st, G. & Karsai, M. Reconstructing social mixing patterns via weighted contact matrices from online and representative surveys. Sci. Rep. 12, 1\u201312 (2022).","journal-title":"Sci. Rep."},{"key":"15633_CR48","unstructured":"Nemzeti Adatv\u00e9delmi \u00e9s Inform\u00e1ci\u00f3szabads\u00e1g Hat\u00f3s\u00e1g. https:\/\/www.naih.hu (date of access 2020.12)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15633-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15633-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15633-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:34:36Z","timestamp":1669354476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15633-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15633"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15633-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,2]]},"assertion":[{"value":"7 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13293"}}